Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial. [electronic resource]
Producer: 20190114Description: 1148-1155 p. digitalISSN:- 1463-1326
- Adult
- Blood Glucose -- analysis
- Blood Glucose Self-Monitoring
- Diabetes Mellitus, Type 1 -- blood
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Compounding
- Drug Monitoring
- Drug Therapy, Combination -- adverse effects
- Female
- Follow-Up Studies
- Glycated Hemoglobin -- analysis
- Humans
- Hyperglycemia -- prevention & control
- Hypoglycemia -- chemically induced
- Hypoglycemic Agents -- administration & dosage
- Insulin Aspart -- administration & dosage
- Insulin Detemir -- administration & dosage
- Male
- Meals
- Middle Aged
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.